Loading the security overview…
Where the tokens are
| Quarter | Reported | EPS | EPS vs year ago | Revenue | Revenue vs year ago | Consensus EPS |
|---|---|---|---|---|---|---|
| Q2 FY26ended Jun 30, 2026 | Aug 10, 2026 | $0.05 | — | $743.17M | +55.6% | $0.04 |
| Q1 FY26ended Mar 31, 2026 | May 12, 2026 | $0.05 | — | $749.19M | +62.0% | $0.03 |
| Q4 FY25ended Dec 31, 2025 | — | −$0.09 | — | $487.71M | +44.7% | — |
| Q3 FY25ended Sep 30, 2025 | — | −$0.05 | — | $496.65M | +50.1% | — |
| Q2 FY25ended Jun 30, 2025 | — | −$0.02 | −300.0% | $477.62M | +34.1% | — |
| Q1 FY25ended Mar 31, 2025 | — | $0.00 | — | $462.33M | +33.3% | — |
| Q4 FY24ended Dec 31, 2024 | — | −$0.04 | — | $336.96M | +7.9% | — |
| Q3 FY24ended Sep 30, 2024 | — | −$0.02 | — | $330.99M | +8.2% | — |
Growth compares each quarter with the same fiscal quarter a year earlier, and is left blank where that quarter is missing or its figure was zero or a loss. Consensus is the estimate published before each report. It usually refers to adjusted EPS, so it is shown beside the GAAP figure rather than subtracted from it: the difference would not be a beat or a miss.
Figures describe Clover Health Investments shares, not any token. As of Aug 10, 2026, from Massive's standardised financials and the earnings calendar.
| Q2 FY24ended Jun 30, 2024 |
| — |
| $0.01 |
| — |
| $356.26M |
| — |
| — |
| Q1 FY24ended Mar 31, 2024 | — | −$0.04 | — | $346.92M | — | — |
| Q4 FY23ended Dec 31, 2023 | — | −$0.14 | — | $312.39M | — | — |
| Q3 FY23ended Sep 30, 2023 | — | −$0.09 | — | $306.03M | — | — |